# Insights from assessment for arrhythmia after CoViD-19 vaccination among Indians

## TL;DR

The study examines arrhythmia after CoViD-19 vaccination in Indians and finds that it is usually mild and temporary.

## Contribution

The study provides insights into arrhythmia risk after CoViD-19 vaccination in the Indian population.

## Key findings

- Post-vaccination myocarditis is typically mild and transient.
- Most cases of arrhythmia resolve quickly with conservative treatment.
- Severe arrhythmias or life-threatening events are unlikely in the general population.

## Abstract

Post-vaccination myocarditis is usually moderate and transient, recovering quickly with conservative treatment. Therefore, it is of
interest to assess for arrhythmia after CoViD-19 vaccination among Indians. We looked for ECG abnormalities in a small cohort of 50
participants after 52 weeks after receiving the Oxford/AstraZeneca CoViD-19 vaccination. Data shows that post-vaccination myocarditis is
typically mild and transient, with most cases resolving swiftly through conservative management. Thus, it is unlikely that this vaccine
will induce severe arrhythmias or life-threatening cardiac events in the general population.